one8zero8 LLC Makes New Investment in Aflac Incorporated (NYSE:AFL)

one8zero8 LLC purchased a new stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,564 shares of the financial services provider's stock, valued at approximately $679,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Raymond James Financial Inc. bought a new stake in Aflac in the 4th quarter worth about $163,409,000. Amundi increased its holdings in Aflac by 81.1% in the 4th quarter. Amundi now owns 2,753,513 shares of the financial services provider's stock worth $285,181,000 after buying an additional 1,232,683 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in Aflac by 471.4% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 600,000 shares of the financial services provider's stock worth $67,080,000 after buying an additional 495,000 shares in the last quarter. Assenagon Asset Management S.A. increased its holdings in Aflac by 670.9% in the 4th quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider's stock worth $57,572,000 after buying an additional 484,378 shares in the last quarter. Finally, World Investment Advisors LLC bought a new stake in Aflac in the 3rd quarter worth about $42,290,000. 67.44% of the stock is currently owned by institutional investors.

Insider Activity at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the sale, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This represents a 3.79 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of the stock in a transaction on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the sale, the director now owns 49,962 shares in the company, valued at $5,360,422.98. The trade was a 37.36 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 55,546 shares of company stock worth $5,863,616. Company insiders own 0.80% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several research firms recently commented on AFL. StockNews.com upgraded Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. Morgan Stanley upped their price target on shares of Aflac from $98.00 to $105.00 and gave the company an "equal weight" rating in a research report on Friday, February 28th. Piper Sandler reduced their price target on shares of Aflac from $122.00 to $118.00 and set an "overweight" rating for the company in a research report on Friday, February 7th. JPMorgan Chase & Co. upped their price target on shares of Aflac from $90.00 to $94.00 and gave the company a "neutral" rating in a research report on Tuesday, January 7th. Finally, Barclays reduced their price target on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating for the company in a research report on Friday, February 7th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $103.36.

Aflac Stock Performance

Shares of NYSE:AFL traded up $0.20 during mid-day trading on Thursday, reaching $108.66. 1,744,675 shares of the company traded hands, compared to its average volume of 1,881,156. The company's 50 day moving average price is $105.70 and its 200-day moving average price is $107.65. The firm has a market cap of $59.39 billion, a PE ratio of 11.32, a PEG ratio of 3.24 and a beta of 0.93. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a 52 week low of $79.31 and a 52 week high of $115.50.

Aflac (NYSE:AFL - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. On average, equities analysts expect that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.